We are live on
!
Find out more
Walleye Capital Portfolio holdings
AUM
$24B
1-Year Est. Return
37.67%
This Fund
S&P 500
This Quarter
Est. Return
-4.15%
1 Year Est. Return
+37.67%
3 Year Est. Return
+98.01%
5 Year Est. Return
+160%
10 Year Est. Return
–
AUM
$1.68B
AUM Growth
+$769M
(+84%)
Cap. Flow
+$831M
Cap. Flow
% of AUM
49.48%
Top 10 Holdings %
Top 10 Hldgs %
8.16%
Holding
2,474
New
799
Increased
624
Reduced
373
Closed
629
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$2.65M |
| 2 |
NFINU
Netfin Acquisition Corp. Unit
NFINU
|
+$2.57M |
| 3 |
ABMD
Abiomed Inc
ABMD
|
+$2.42M |
| 4 |
Humana
HUM
|
+$2.37M |
| 5 |
Cigna
CI
|
+$2.29M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JFKKU
8i Enterprises Acquisition Corp Unit
JFKKU
|
+$1.58M |
| 2 |
GIX.U
GigCapital2, Inc.
GIX.U
|
+$1.35M |
| 3 |
Sarepta Therapeutics
SRPT
|
+$1.31M |
| 4 |
CHAC.U
Chardan Healthcare Acquisition Corp.
CHAC.U
|
+$1.27M |
| 5 |
Artisan Partners
APAM
|
+$1.24M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 1.91% |
| 2 | Technology | 1.1% |
| 3 | Consumer Discretionary | 1.05% |
| 4 | Communication Services | 0.58% |
| 5 | Materials | 0.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1326
PUT
Conagra Brands
CAG
$7.39B
| $141K | 0.01% |
+4,600
| New | +$132K |
|
|
CLVS
1327
PUT
DELISTED
Clovis Oncology, Inc.
CLVS
| $141K | 0.01% |
35,800
+5,700
| +19% | +$46.1K |
|
|
CZR
1328
CALL
DELISTED
Caesars Entertainment Corporation
CZR
| $141K | 0.01% |
+12,100
| New | +$142K |
|
1329
CALL
PENN Entertainment
PENN
$2.83B
| $140K | 0.01% |
7,500
-10,500
| -58% | -$199K |
|
1330
PUT
Aramark
ARMK
$15.1B
| $139K | 0.01% |
4,432
-970
| -18% | -$27.3K |
|
1331
CALL
Commault Systems
CVLT
$4.97B
| $139K | 0.01% |
3,100
-2,600
| -46% | -$119K |
|
1332
GameStop
GME
$9.94B
| $139K | 0.01% |
100,496
+96,816
| +2,631% | +$105K |
|
1333
CALL
Vistra
VST
$50.1B
| $139K | 0.01% |
5,200
-11,700
| -69% | -$278K |
|
1334
CALL
Intellia Therapeutics
NTLA
$1.52B
| $138K | 0.01% |
10,300
-200
| -2% | -$3.19K |
|
|
S
1335
PUT
DELISTED
Sprint Corporation
S
| $138K | 0.01% |
+22,300
| New | +$153K |
|
|
ITCI
1336
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $137K | 0.01% |
+18,300
| New | +$175K |
|
1337
PUT
Cohu
COHU
$2B
| $136K | 0.01% |
+10,100
| New | +$140K |
|
1338
PUT
Williams-Sonoma
WSM
$27.8B
| $136K | 0.01% |
+4,000
| New | +$132K |
|
|
TLRD
1339
DELISTED
Tailored Brands, Inc.
TLRD
| $136K | 0.01% |
31,000
-4,698
| -13% | -$23.8K |
|
1340
CALL
Terex
TEX
$7.84B
| $135K | 0.01% |
+5,200
| New | +$143K |
|
|
MNDT
1341
PUT
DELISTED
Mandiant, Inc. Common Stock
MNDT
| $135K | 0.01% |
10,100
-25,400
| -72% | -$361K |
|
|
CBIO
1342
Crescent Biopharma
CBIO
$610M
| $134K | 0.01% |
+310
| New | +$199K |
|
1343
CALL
Hilltop Holdings
HTH
$2.28B
| $134K | 0.01% |
5,600
-9,000
| -62% | -$206K |
|
|
IPHI
1344
PUT
DELISTED
INPHI CORPORATION
IPHI
| $134K | 0.01% |
+2,200
| New | +$134K |
|
1345
Burlington
BURL
$23.3B
| $133K | 0.01% |
+665
| New | +$122K |
|
1346
Amgen
AMGN
$212B
| $132K | 0.01% |
680
+280
| +70% | +$53.7K |
|
|
QIWI
1347
PUT
DELISTED
QIWI PLC
QIWI
| $132K | 0.01% |
+6,000
| New | +$130K |
|
1348
CALL
Beazer Homes USA
BZH
$914M
| $131K | 0.01% |
+8,800
| New | +$106K |
|
1349
PUT
QuinStreet
QNST
$916M
| $131K | 0.01% |
+10,400
| New | +$142K |
|
1350
PUT
Unisys
UIS
$251M
| $131K | 0.01% |
17,600
-19,200
| -52% | -$171K |
|
Similar funds
JG
SC
OAG
CS
Walleye Capital's Q3 2019 Portfolio in Review
As of Q3 2019, Walleye Capital held 2,474 positions worth $1.68B, up 84% from $910M the previous quarter. Its ten largest holdings account for 8.2% of the portfolio.
Walleye Capital deployed $831M of net new capital in Q3 2019, opening 799 new positions and adding to 624 existing holdings. Its largest new stake was Meta Platforms (Facebook): 13,918 shares worth $2.48M.
By sector, the portfolio is most concentrated in Healthcare at 1.9% of assets, up from 1.8% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Arqule Inc, an estimated $1.22M trimmed.
- Walleye Capital's largest Q3 2019 buy was Meta Platforms (Facebook): 13,918 shares worth $2.48M.
- Walleye Capital added most to Abiomed Inc in Q3 2019, an estimated $2.42M increase.
- Walleye Capital's biggest Q3 2019 reduction was Arqule Inc, cutting an estimated $1.22M.
- Walleye Capital fully exited 8i Enterprises Acquisition Corp Unit in Q3 2019, selling an estimated $1.58M.
- Walleye Capital's ten largest holdings make up 8.2% of its $1.68B portfolio in Q3 2019.
- Walleye Capital opened 799 new positions and closed 629 in Q3 2019.
- Walleye Capital's portfolio value rose 84% quarter-over-quarter to $1.68B.
Based on Walleye Capital's 13F filing for Q3 2019, filed 14 Nov 2019.